GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicus Pharma Ltd (OTCPK:MDPLF) » Definitions » Cash Ratio

Medicus Pharma (Medicus Pharma) Cash Ratio : 1.58 (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Medicus Pharma Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Medicus Pharma's Cash Ratio for the quarter that ended in Dec. 2023 was 1.58.

Medicus Pharma has a Cash Ratio of 1.58. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Medicus Pharma's Cash Ratio or its related term are showing as below:

MDPLF' s Cash Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.02   Max: 1.58
Current: 1.58

During the past 3 years, Medicus Pharma's highest Cash Ratio was 1.58. The lowest was 0.01. And the median was 0.02.

MDPLF's Cash Ratio is ranked better than
73.52% of 1027 companies
in the Drug Manufacturers industry
Industry Median: 0.55 vs MDPLF: 1.58

Medicus Pharma Cash Ratio Historical Data

The historical data trend for Medicus Pharma's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicus Pharma Cash Ratio Chart

Medicus Pharma Annual Data
Trend Dec21 Dec22 Dec23
Cash Ratio
0.01 0.02 1.58

Medicus Pharma Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Ratio Get a 7-Day Free Trial Premium Member Only 0.02 - 0.01 3.19 1.58

Competitive Comparison of Medicus Pharma's Cash Ratio

For the Drug Manufacturers - General subindustry, Medicus Pharma's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicus Pharma's Cash Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicus Pharma's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Medicus Pharma's Cash Ratio falls into.



Medicus Pharma Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Medicus Pharma's Cash Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash Ratio (A: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=1.719/1.087
=1.58

Medicus Pharma's Cash Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash Ratio (Q: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=1.719/1.087
=1.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medicus Pharma  (OTCPK:MDPLF) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Medicus Pharma Cash Ratio Related Terms

Thank you for viewing the detailed overview of Medicus Pharma's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicus Pharma (Medicus Pharma) Business Description

Comparable Companies
Traded in Other Exchanges
Address
100 King Street West, Suite 3400, One First Canadian Place, Toronto, ON, CAN, M5X 1A4
Medicus Pharma Ltd will carry on the business of pharmaceutical drug development focused initially on SkinJect. The objective of SkinJect is developing and commercializing novel microneedle arrays for the purpose of treating certain skin cancers, initially basal cell carcinoma.

Medicus Pharma (Medicus Pharma) Headlines

From GuruFocus

Medicus Pharma Opens the Market

By PRNewswire 10-26-2023